位置:首页 > 蛋白库 > CLOCK_SPAJD
CLOCK_SPAJD
ID   CLOCK_SPAJD             Reviewed;         865 AA.
AC   Q91YA8;
DT   28-NOV-2006, integrated into UniProtKB/Swiss-Prot.
DT   01-DEC-2001, sequence version 1.
DT   25-MAY-2022, entry version 111.
DE   RecName: Full=Circadian locomoter output cycles protein kaput;
DE            EC=2.3.1.48;
GN   Name=Clock;
OS   Spalax judaei (Judean Mountains blind mole rat) (Nannospalax judaei).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea;
OC   Spalacidae; Spalacinae; Nannospalax.
OX   NCBI_TaxID=134510;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Brain;
RX   PubMed=11707566; DOI=10.1073/pnas.181484498;
RA   Avivi A., Albrecht U., Oster H., Joel A., Beiles A., Nevo E.;
RT   "Biological clock in total darkness: the Clock/MOP3 circadian system of the
RT   blind subterranean mole rat.";
RL   Proc. Natl. Acad. Sci. U.S.A. 98:13751-13756(2001).
CC   -!- FUNCTION: Transcriptional activator which forms a core component of the
CC       circadian clock. The circadian clock, an internal time-keeping system,
CC       regulates various physiological processes through the generation of
CC       approximately 24 hour circadian rhythms in gene expression, which are
CC       translated into rhythms in metabolism and behavior. It is derived from
CC       the Latin roots 'circa' (about) and 'diem' (day) and acts as an
CC       important regulator of a wide array of physiological functions
CC       including metabolism, sleep, body temperature, blood pressure,
CC       endocrine, immune, cardiovascular, and renal function. Consists of two
CC       major components: the central clock, residing in the suprachiasmatic
CC       nucleus (SCN) of the brain, and the peripheral clocks that are present
CC       in nearly every tissue and organ system. Both the central and
CC       peripheral clocks can be reset by environmental cues, also known as
CC       Zeitgebers (German for 'timegivers'). The predominant Zeitgeber for the
CC       central clock is light, which is sensed by retina and signals directly
CC       to the SCN. The central clock entrains the peripheral clocks through
CC       neuronal and hormonal signals, body temperature and feeding-related
CC       cues, aligning all clocks with the external light/dark cycle. Circadian
CC       rhythms allow an organism to achieve temporal homeostasis with its
CC       environment at the molecular level by regulating gene expression to
CC       create a peak of protein expression once every 24 hours to control when
CC       a particular physiological process is most active with respect to the
CC       solar day. Transcription and translation of core clock components
CC       (CLOCK, NPAS2, ARNTL/BMAL1, ARNTL2/BMAL2, PER1, PER2, PER3, CRY1 and
CC       CRY2) plays a critical role in rhythm generation, whereas delays
CC       imposed by post-translational modifications (PTMs) are important for
CC       determining the period (tau) of the rhythms (tau refers to the period
CC       of a rhythm and is the length, in time, of one complete cycle). A
CC       diurnal rhythm is synchronized with the day/night cycle, while the
CC       ultradian and infradian rhythms have a period shorter and longer than
CC       24 hours, respectively. Disruptions in the circadian rhythms contribute
CC       to the pathology of cardiovascular diseases, cancer, metabolic
CC       syndromes and aging. A transcription/translation feedback loop (TTFL)
CC       forms the core of the molecular circadian clock mechanism.
CC       Transcription factors, CLOCK or NPAS2 and ARNTL/BMAL1 or ARNTL2/BMAL2,
CC       form the positive limb of the feedback loop, act in the form of a
CC       heterodimer and activate the transcription of core clock genes and
CC       clock-controlled genes (involved in key metabolic processes), harboring
CC       E-box elements (5'-CACGTG-3') within their promoters. The core clock
CC       genes: PER1/2/3 and CRY1/2 which are transcriptional repressors form
CC       the negative limb of the feedback loop and interact with the
CC       CLOCK|NPAS2-ARNTL/BMAL1|ARNTL2/BMAL2 heterodimer inhibiting its
CC       activity and thereby negatively regulating their own expression. This
CC       heterodimer also activates nuclear receptors NR1D1/2 and RORA/B/G,
CC       which form a second feedback loop and which activate and repress
CC       ARNTL/BMAL1 transcription, respectively. Regulates the circadian
CC       expression of ICAM1, VCAM1, CCL2, THPO and MPL and also acts as an
CC       enhancer of the transactivation potential of NF-kappaB. Plays an
CC       important role in the homeostatic regulation of sleep. The CLOCK-
CC       ARNTL/BMAL1 heterodimer regulates the circadian expression of
CC       SERPINE1/PAI1, VWF, B3, CCRN4L/NOC, NAMPT, DBP, MYOD1, PPARGC1A,
CC       PPARGC1B, SIRT1, GYS2, F7, NGFR, GNRHR, BHLHE40/DEC1, ATF4, MTA1, KLF10
CC       and also genes implicated in glucose and lipid metabolism. Promotes
CC       rhythmic chromatin opening, regulating the DNA accessibility of other
CC       transcription factors. The CLOCK-ARNTL2/BMAL2 heterodimer activates the
CC       transcription of SERPINE1/PAI1 and BHLHE40/DEC1. The preferred binding
CC       motif for the CLOCK-ARNTL/BMAL1 heterodimer is 5'-CACGTGA-3', which
CC       contains a flanking Ala residue in addition to the canonical 6-
CC       nucleotide E-box sequence. CLOCK specifically binds to the half-site
CC       5'-CAC-3', while ARNTL binds to the half-site 5'-GTGA-3'. The CLOCK-
CC       ARNTL/BMAL1 heterodimer also recognizes the non-canonical E-box motifs
CC       5'-AACGTGA-3' and 5'-CATGTGA-3'. CLOCK has an intrinsic
CC       acetyltransferase activity, which enables circadian chromatin
CC       remodeling by acetylating histones and nonhistone proteins, including
CC       its own partner ARNTL/BMAL1. Represses glucocorticoid receptor
CC       NR3C1/GR-induced transcriptional activity by reducing the association
CC       of NR3C1/GR to glucocorticoid response elements (GREs) via the
CC       acetylation of multiple lysine residues located in its hinge region.
CC       The acetyltransferase activity of CLOCK is as important as its
CC       transcription activity in circadian control. Acetylates metabolic
CC       enzymes IMPDH2 and NDUFA9 in a circadian manner. Facilitated by BMAL1,
CC       rhythmically interacts and acetylates argininosuccinate synthase 1
CC       (ASS1) leading to enzymatic inhibition of ASS1 as well as the circadian
CC       oscillation of arginine biosynthesis and subsequent ureagenesis (By
CC       similarity). Drives the circadian rhythm of blood pressure through
CC       transcriptional activation of ATP1B1 (By similarity).
CC       {ECO:0000250|UniProtKB:O08785, ECO:0000250|UniProtKB:O15516}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=acetyl-CoA + L-lysyl-[protein] = CoA + H(+) + N(6)-acetyl-L-
CC         lysyl-[protein]; Xref=Rhea:RHEA:45948, Rhea:RHEA-COMP:9752,
CC         Rhea:RHEA-COMP:10731, ChEBI:CHEBI:15378, ChEBI:CHEBI:29969,
CC         ChEBI:CHEBI:57287, ChEBI:CHEBI:57288, ChEBI:CHEBI:61930; EC=2.3.1.48;
CC   -!- SUBUNIT: Component of the circadian clock oscillator which includes the
CC       CRY proteins, CLOCK or NPAS2, ARNTL/BMAL1 or ARNTL2/BMAL2, CSNK1D
CC       and/or CSNK1E, TIMELESS and the PER proteins (By similarity). Forms a
CC       heterodimer with ARNTL/BMAL1 (By similarity). The CLOCK-ARNTL/BMAL1
CC       heterodimer is required for E-box-dependent transactivation, for CLOCK
CC       nuclear translocation and degradation, and for phosphorylation of both
CC       CLOCK and ARNTL/BMAL1 (By similarity). Interacts with NR3C1 in a
CC       ligand-dependent fashion (By similarity). Interacts with ESR1 and
CC       estrogen stimulates this interaction (By similarity). Interacts with
CC       the complex p35/CDK5 (By similarity). Interacts with RELA/p65 (By
CC       similarity). Interacts with KAT2B, CREBBP and EP300 (By similarity).
CC       Interacts with ID1 and ID3 (By similarity). Interacts with ID2 (By
CC       similarity). Interacts with MTA1 (By similarity). Interacts with OGA
CC       (By similarity). Interacts with SIRT1 (By similarity). Interacts with
CC       CIPC (By similarity). Interacts with EZH2 (By similarity). Interacts
CC       with EIF4E, PIWIL1 and DDX4 (By similarity). Interacts with PER1, PER2,
CC       CRY1 and CRY2 and this interaction requires a translocation to the
CC       nucleus (By similarity). Interaction of the CLOCK-ARNTL/BMAL1
CC       heterodimer with PER or CRY inhibits transcription activation (By
CC       similarity). Interaction of the CLOCK-ARNTL/BMAL1 with CRY1 is
CC       independent of DNA but with PER2 is off DNA (By similarity). The CLOCK-
CC       ARNTL/BMAL1 heterodimer interacts with GSK3B (By similarity). Interacts
CC       with KDM5A (By similarity). Interacts with KMT2A; in a circadian manner
CC       (By similarity). Interacts with MYBBP1A (By similarity). Interacts with
CC       THRAP3 (By similarity). Interacts with MED1; this interaction requires
CC       the presence of THRAP3 (By similarity). Interacts with NCOA2 (By
CC       similarity). The CLOCK-ARNTL/BMAL1 heterodimer interacts with PASD1.
CC       Interacts with ASS1 and IMPDH2; in a circadian manner. Interacts with
CC       NDUFA9 (By similarity). Interacts with PIWIL2 (via PIWI domain) (By
CC       similarity). Interacts with HNF4A (By similarity).
CC       {ECO:0000250|UniProtKB:O08785, ECO:0000250|UniProtKB:O15516}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:O08785}. Nucleus
CC       {ECO:0000255|PROSITE-ProRule:PRU00981}. Cytoplasm, cytosol
CC       {ECO:0000250|UniProtKB:O15516}. Note=Localizes to sites of DNA damage
CC       in a H2AX-independent manner. Shuttling between the cytoplasm and the
CC       nucleus is under circadian regulation and is ARNTL/BMAL1-dependent.
CC       Sequestered to the cytoplasm in the presence of ID2.
CC       {ECO:0000250|UniProtKB:O08785}.
CC   -!- PTM: Ubiquitinated, leading to its proteasomal degradation.
CC       {ECO:0000250|UniProtKB:O08785}.
CC   -!- PTM: O-glycosylated; contains O-GlcNAc. O-glycosylation by OGT prevents
CC       protein degradation by inhibiting ubiquitination. It also stabilizes
CC       the CLOCK-ARNTL/BMAL1 heterodimer thereby increasing CLOCK-ARNTL/BMAL1-
CC       mediated transcriptional activation of PER1/2/3 and CRY1/2.
CC       {ECO:0000250|UniProtKB:O08785}.
CC   -!- PTM: Phosphorylation is dependent on the CLOCK-ARNTL/BMAL1 heterodimer
CC       formation. Phosphorylation enhances the transcriptional activity,
CC       alters the subcellular localization and decreases the stability of the
CC       heterodimer by promoting its degradation. Phosphorylation shows
CC       circadian variations in the liver. May be phosphorylated by CSNK1D and
CC       CKSN1E. {ECO:0000250|UniProtKB:O08785}.
CC   -!- PTM: Sumoylation enhances its transcriptional activity and interaction
CC       with ESR1, resulting in up-regulation of ESR1 activity. Estrogen
CC       stimulates sumoylation. Desumoylation by SENP1 negatively regulates its
CC       transcriptional activity. {ECO:0000250|UniProtKB:O08785}.
CC   -!- PTM: Undergoes lysosome-mediated degradation in a time-dependent manner
CC       in the liver. {ECO:0000250|UniProtKB:O08785}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AJ318059; CAC85405.1; -; mRNA.
DR   AlphaFoldDB; Q91YA8; -.
DR   SMR; Q91YA8; -.
DR   PRIDE; Q91YA8; -.
DR   GO; GO:0033391; C:chromatoid body; ISS:UniProtKB.
DR   GO; GO:0005829; C:cytosol; ISS:UniProtKB.
DR   GO; GO:0005634; C:nucleus; ISS:UniProtKB.
DR   GO; GO:0005667; C:transcription regulator complex; ISS:UniProtKB.
DR   GO; GO:0031490; F:chromatin DNA binding; ISS:UniProtKB.
DR   GO; GO:0003677; F:DNA binding; ISS:UniProtKB.
DR   GO; GO:0003700; F:DNA-binding transcription factor activity; ISS:UniProtKB.
DR   GO; GO:0070888; F:E-box binding; ISS:UniProtKB.
DR   GO; GO:0004402; F:histone acetyltransferase activity; ISS:UniProtKB.
DR   GO; GO:0046983; F:protein dimerization activity; IEA:InterPro.
DR   GO; GO:0000978; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; ISS:UniProtKB.
DR   GO; GO:0043565; F:sequence-specific DNA binding; ISS:UniProtKB.
DR   GO; GO:0006974; P:cellular response to DNA damage stimulus; IEA:UniProtKB-KW.
DR   GO; GO:0032922; P:circadian regulation of gene expression; ISS:UniProtKB.
DR   GO; GO:2000323; P:negative regulation of glucocorticoid receptor signaling pathway; ISS:UniProtKB.
DR   GO; GO:0045892; P:negative regulation of transcription, DNA-templated; ISS:UniProtKB.
DR   GO; GO:0051092; P:positive regulation of NF-kappaB transcription factor activity; ISS:UniProtKB.
DR   GO; GO:0045893; P:positive regulation of transcription, DNA-templated; ISS:UniProtKB.
DR   GO; GO:0043161; P:proteasome-mediated ubiquitin-dependent protein catabolic process; ISS:UniProtKB.
DR   GO; GO:0006473; P:protein acetylation; ISS:UniProtKB.
DR   GO; GO:0042752; P:regulation of circadian rhythm; ISS:UniProtKB.
DR   GO; GO:0042634; P:regulation of hair cycle; ISS:UniProtKB.
DR   GO; GO:0050796; P:regulation of insulin secretion; ISS:UniProtKB.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; ISS:UniProtKB.
DR   GO; GO:2000074; P:regulation of type B pancreatic cell development; ISS:UniProtKB.
DR   GO; GO:0051775; P:response to redox state; ISS:UniProtKB.
DR   GO; GO:0007283; P:spermatogenesis; ISS:UniProtKB.
DR   CDD; cd00130; PAS; 2.
DR   Gene3D; 4.10.280.10; -; 1.
DR   InterPro; IPR011598; bHLH_dom.
DR   InterPro; IPR036638; HLH_DNA-bd_sf.
DR   InterPro; IPR001067; Nuc_translocat.
DR   InterPro; IPR001610; PAC.
DR   InterPro; IPR000014; PAS.
DR   InterPro; IPR035965; PAS-like_dom_sf.
DR   InterPro; IPR013767; PAS_fold.
DR   Pfam; PF00010; HLH; 1.
DR   Pfam; PF00989; PAS; 1.
DR   PRINTS; PR00785; NCTRNSLOCATR.
DR   SMART; SM00353; HLH; 1.
DR   SMART; SM00086; PAC; 1.
DR   SMART; SM00091; PAS; 2.
DR   SUPFAM; SSF47459; SSF47459; 1.
DR   SUPFAM; SSF55785; SSF55785; 2.
DR   PROSITE; PS50888; BHLH; 1.
DR   PROSITE; PS50112; PAS; 2.
PE   2: Evidence at transcript level;
KW   Activator; Biological rhythms; Cytoplasm; DNA damage; DNA-binding;
KW   Isopeptide bond; Nucleus; Phosphoprotein; Repeat; Transcription;
KW   Transcription regulation; Transferase; Ubl conjugation.
FT   CHAIN           1..865
FT                   /note="Circadian locomoter output cycles protein kaput"
FT                   /id="PRO_0000262641"
FT   DOMAIN          34..84
FT                   /note="bHLH"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00981"
FT   DOMAIN          107..177
FT                   /note="PAS 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00140"
FT   DOMAIN          262..332
FT                   /note="PAS 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00140"
FT   DOMAIN          336..379
FT                   /note="PAC"
FT   REGION          371..864
FT                   /note="Interaction with NR3C1"
FT                   /evidence="ECO:0000250|UniProtKB:O08785"
FT   REGION          392..411
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          420..494
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          450..570
FT                   /note="Interaction with SIRT1"
FT                   /evidence="ECO:0000250|UniProtKB:O08785"
FT   REGION          514..564
FT                   /note="Implicated in the circadian rhythmicity"
FT                   /evidence="ECO:0000250"
FT   REGION          620..653
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          755..803
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          822..865
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOTIF           32..47
FT                   /note="Nuclear localization signal"
FT                   /evidence="ECO:0000250|UniProtKB:O08785"
FT   COMPBIAS        427..464
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        475..494
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   SITE            39
FT                   /note="Interaction with E-box DNA"
FT                   /evidence="ECO:0000250|UniProtKB:O15516"
FT   SITE            43
FT                   /note="Interaction with E-box DNA"
FT                   /evidence="ECO:0000250|UniProtKB:O15516"
FT   SITE            47
FT                   /note="Interaction with E-box DNA"
FT                   /evidence="ECO:0000250|UniProtKB:O15516"
FT   SITE            84
FT                   /note="Important for interaction with ARNTL/BMAL1"
FT                   /evidence="ECO:0000250|UniProtKB:O15516"
FT   MOD_RES         38
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:O08785"
FT   MOD_RES         42
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:O08785"
FT   MOD_RES         408
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:O08785"
FT   MOD_RES         427
FT                   /note="Phosphoserine; by GSK3-beta"
FT                   /evidence="ECO:0000250|UniProtKB:O08785"
FT   MOD_RES         431
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:O08785"
FT   MOD_RES         451
FT                   /note="Phosphothreonine; by CDK5"
FT                   /evidence="ECO:0000250|UniProtKB:O15516"
FT   MOD_RES         461
FT                   /note="Phosphothreonine; by CDK5"
FT                   /evidence="ECO:0000250|UniProtKB:O15516"
FT   CROSSLNK        861
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO1)"
FT                   /evidence="ECO:0000250|UniProtKB:O08785"
SQ   SEQUENCE   865 AA;  97421 MW;  B85AB1B359A5750B CRC64;
     MLFTVSCSKM SSIVDRDDSS IFDGLVEEDD KNKAKRVSRN KSEKKRRDQF NVLIKELGSM
     LPGNAREMDK STVLQKSIDF LRKHKEITAQ SDASEIRQDW KPTFLSNEEF TQLMLEALDG
     FFLAIMTDGS IIYVSESVTS LLEHLPSDLV DQSVFNFIPE GEHSEVYKIL STHLLESDSL
     TPEYLKSKNQ LEFCCHMLRG TIDPKEPSTY EYMRFIGNFK SLNSVPTSAH NGFEGTIQRT
     HRLSYEDRVC SVATVRLATP QFIKEMCTVE EPNEEFTSRH SLEWKFLFLD HRAPPIIGYL
     PFEVLGTSGY DYYHVDDLEN LAKCHEHLMQ YGKGKSCYYR FLTKGQQWIW LQTHYYITYH
     QWNSRPEFIV CTHTVVSYAE VRAERRRELG IEESLPDATA DKGQDSGSDN RINTVSLKEA
     LERFDHSPTP SASSRSSRKS SHTAVSDPSS TPTKIPTDTS TPPRQHLPAH EKMAQRRSSF
     SSQSMNSQSV GPSLTQPVIS QAANLPVPQG MSQFQFSAQL GAMQHLKDQL EQRTRMIEAN
     IHRQQEELRK IQEQLQMVHG QGLQMFLQQS NPGLNFGSVQ LSSGNSSNIQ QLTPINMQGQ
     VVPTNQIQSG MNAGHIGTSQ HLIQQQSLQS TSTQQSQQSV MSGHSQQTSL ASQTQSTLTA
     PLYNTMVISQ PAPGSMVQIP SSMPQNSTQS ATVTTFTQDR QIRFSQGQQL VTKLVTAPVA
     CGAVMVPSTM LMGQVVTAYP TFATQQQQAQ TLSVTQQQPQ QQQPQQQQPQ QQQPQQQQQS
     SQEQQLPSVP QPSQAQLTQS PQQFLQTSRL LHGNPSTQLI LSAAFPLQQS TFPPSHHQQH
     QSQQQQQLSR HRTDSLTDPS KVQPQ
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2025